110 related articles for article (PubMed ID: 3521781)
1. Origin of carcinomas causing bladder neck obstruction demonstrated by immunoperoxidase localisation of specific antigens.
Al Adnani MS
Br J Urol; 1986 Jun; 58(3):283-6. PubMed ID: 3521781
[TBL] [Abstract][Full Text] [Related]
2. Immunocytochemical localisation of prostate-specific antigen: specificity and application to clinical practice.
Ford TF; Butcher DN; Masters JR; Parkinson MC
Br J Urol; 1985 Feb; 57(1):50-5. PubMed ID: 2578846
[TBL] [Abstract][Full Text] [Related]
3. [Immunohistochemical demonstration of tumor-associated antigens in urinary bladder carcinomas using mono- and polyclonal antisera].
Friedmann W; Steffens J; Lobeck H
Onkologie; 1985 Apr; 8(2):105-10. PubMed ID: 2582324
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical demonstration of tumor-associated antigens in prostatic carcinomas of various histological differentiations.
Friedmann W; Steffens J; Lobeck H; Blümcke S; Nagel R
Eur Urol; 1985; 11(1):52-6. PubMed ID: 2580711
[TBL] [Abstract][Full Text] [Related]
5. Epithelial markers in prostatic, bladder, and colorectal cancer: an immunoperoxidase study of epithelial membrane antigen, carcinoembryonic antigen, and prostatic acid phosphatase.
Heyderman E; Brown BM; Richardson TC
J Clin Pathol; 1984 Dec; 37(12):1363-9. PubMed ID: 6392348
[TBL] [Abstract][Full Text] [Related]
6. Immunophenotype of high-grade prostatic adenocarcinoma and urothelial carcinoma.
Genega EM; Hutchinson B; Reuter VE; Gaudin PB
Mod Pathol; 2000 Nov; 13(11):1186-91. PubMed ID: 11106075
[TBL] [Abstract][Full Text] [Related]
7. Schistosomiasis, metaplasia and squamous cell carcinoma of the prostate: histogenesis of the squamous cancer cells determined by localization of specific markers.
Al Adnani MS
Neoplasma; 1985; 32(5):613-22. PubMed ID: 2415839
[TBL] [Abstract][Full Text] [Related]
8. Prostatic origin of metastases: immunoperoxidase localization of prostate-specific antigen.
Ghazizadeh M; Kagawa S; Maebayashi K; Izumi K; Kurokawa K
Urol Int; 1984; 39(1):9-12. PubMed ID: 6203202
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical localization of prostate carcinoma-associated antigens.
Wright GL; Beckett ML; Starling JJ; Schellhammer PF; Sieg SM; Ladaga LE; Poleskic S
Cancer Res; 1983 Nov; 43(11):5509-16. PubMed ID: 6193873
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer-associated markers.
Chu TM
Immunol Ser; 1990; 53():339-56. PubMed ID: 1713065
[TBL] [Abstract][Full Text] [Related]
11. Studies of monoclonal antibody BL2-10D1 as a marker for the detection of the urothelial origin of tumors.
Longin A; Berger-Dutrieux N; Fontaniere B; Cochran AJ; Devonec M; Dolbeau D; Guillaud M; Laurent JC
Cancer; 1993 Nov; 72(9):2651-5. PubMed ID: 7691394
[TBL] [Abstract][Full Text] [Related]
12. Immunoperoxidase staining of carcinoembryonic antigen in urinary bladder cancer.
Goldenberg DM; Wahren B
Urol Res; 1978; 6(4):211-4. PubMed ID: 369084
[TBL] [Abstract][Full Text] [Related]
13. Behavior of epithelial differentiation antigens (carcinoembryonic antigen, epithelial membrane antigen, keratin and cytokeratin) in transitional cell carcinomas of the bladder.
Sánchez-Fernández de Sevilla MC; Morell-Quadreny L; Gil-Salom M; Pérez-Bacete M; Fenollosa-Entrena B; Llombart-Bosch A
Urol Int; 1992; 48(1):14-9. PubMed ID: 1376008
[TBL] [Abstract][Full Text] [Related]
14. Prostate-specific acid phosphatase immunoreactivity in adenocarcinomas of the urinary bladder.
Epstein JI; Kuhajda FP; Lieberman PH
Hum Pathol; 1986 Sep; 17(9):939-42. PubMed ID: 2428729
[TBL] [Abstract][Full Text] [Related]
15. Use of monoclonal antibody E48 in diagnosing transitional cell carcinoma of urinary bladder.
Torenbeek R; Blomjous CE; Quak JJ; Ybema S; Meijer CJ
J Clin Pathol; 1992 Apr; 45(4):303-7. PubMed ID: 1374431
[TBL] [Abstract][Full Text] [Related]
16. [Immunohistochemical diagnosis of metastasizing prostatic carcinomas].
Friedmann W; Steffens J; Lobeck H
Onkologie; 1984 Dec; 7(6):337-41. PubMed ID: 6084838
[TBL] [Abstract][Full Text] [Related]
17. Changes of phenotypic expression of prostatic antigen in secondary transitional cell carcinoma of the prostate: evidence for induction phenomenon as a mechanism for acquisition of prostatic antigens in prostatic transitional cell carcinoma.
Mai KT; Yazdi HM; Farmer J
Prostate; 2001 May; 47(3):172-82. PubMed ID: 11351346
[TBL] [Abstract][Full Text] [Related]
18. Keratin, luminal epithelial antigen and carcinoembryonic antigen in human urinary bladder carcinomas. An immunohistochemical study.
Nathrath WB; Arnholdt H; Wilson PD
Pathol Res Pract; 1982; 175(2-3):299-307. PubMed ID: 6190152
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical expression of prostatic antigens in adenocarcinoma and villous adenoma of the urinary bladder.
Lane Z; Hansel DE; Epstein JI
Am J Surg Pathol; 2008 Sep; 32(9):1322-6. PubMed ID: 18670358
[TBL] [Abstract][Full Text] [Related]
20. [The value of histochemical detection of prostate specific antigen].
Hashimoto H; Yachiku S; Nishihara M; Arima S; Tokunaka S; Inada F
Nihon Hinyokika Gakkai Zasshi; 1987 Aug; 78(8):1319-22. PubMed ID: 2449558
[No Abstract] [Full Text] [Related]
[Next] [New Search]
